Articles tagged "Graft acceptance"

2020 American Transplant Congress
Dual Kidney Transplantation Offers a Safe and Effective Way to Use Kidneys from Deceased Donors Older Than 70 Years
K. Lee, J. Park, S. Cha, M. Kim
Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Dual kidney transplantation (DKT) offers a way to extend the use of kidneys from expanded criteria donors (ECDs). Here, we compared the outcomes of…
2020 American Transplant Congress
The Impact of Occult Graft Fibrosis on Clinical Outcomes in Human Liver Transplant Recipients
H. Hirao¹, T. Ito¹, B. V. Naini¹, K. Nakamura², S. Kageyama¹, K. Kadono¹, H. Kojima¹, K. J. Dery¹, S. Younan¹, F. M. Kaldas¹, R. W. Busuttil¹, J. W. Kupiec-Weglinski¹
¹UCLA, Los Angeles, CA, ²Kyoto University, Kyoto, Japan
*Purpose: Although liver transplantation (LT) has become a standard therapy for end-stage liver disease, early allograft dysfunction (EAD) and graft rejection remain serious unsolved problems.…
2020 American Transplant Congress
Geographic Discard Disparities of Liver Allografts
P. I. Kenny Jr¹, A. Rana², J. Vierling²
¹Medical Student, Baylor College of Medicine, Houston, TX, ²Baylor College of Medicine, Houston, TX
*Purpose: The aim of this study is to demonstrate the significant geographic disparity in liver allograft discard.*Methods: Using the OPTN Diseased Donor Network database, we…
2020 American Transplant Congress
Predicting Kidney Allograft Discard: The Kidney Discard Risk Index
M. B. Price, M. Joshi, T. Zhang, J. Vierling, T. Galvan, R. Cotton, C. O'Mahony, J. Goss, A. Rana
Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: The disparity between the supply and demand for kidney allografts is exacerbated by an 18.9% discard rate. It is our aim to determine predictors…
2020 American Transplant Congress
Report of Organ Offers Linked with Instant Messaging Data Provides a Basis for Quality Improvement
E. Pahl
Health Informatics, University of Iowa, Iowa City, IA
*Purpose: Thousands of viable organs are discarded every year with incorrect or inappropriate reasons for declination. One limitation on the accessibility of organ transplantation is…
2020 American Transplant Congress
Trends in Transplant Center Responses to the Minimum Acceptance Criteria Across UNOS Regions, 2007-2019
E. M. Roth¹, Q. Yuan², N. Elias²
¹Harvard Medical School, Boston, MA, ²Transplant Center, Massachusetts General Hospital, Boston, MA
*Purpose: The objective of this study was to examine trends in transplant center willingness to accept organs from Public Health Service increased-risk donors for infectious…
2020 American Transplant Congress
Defining the Psychological Profile of Living Organ Donors Using Personality Assessment Inventory
W. T. Branagan¹, S. Huett¹, M. Grafals², W. E. Jackson³, E. A. Pomfret⁴
¹Division of Psychiatry, University of Colorado, Aurora, CO, ²Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO, ³Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ⁴Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: We aim to assess the psychological profile of living organ donors using normative referenced psychological assessment of personality and pathology.*Methods: Evaluation for living kidney…
2020 American Transplant Congress
Change in the Willingness of Transplant Candidates to Accept Hepatitis C Virus Positive Deceased Donor Organs in the Era of Direct-Acting Antivirals
Q. Yuan, S. Hong, E. Roth, M. Sise, E. Bethea, W. Williams, H. Yeh, N. Elias
Transplant Center, Massachusetts General Hospital，Harvard Medical School, Boston, MA
*Purpose: Direct-acting antiviral (DAA) medications’ advent in 2014 very effectively changed the hepatitis C virus (HCV) treatment landscape and allowed post-transplant HCV therapy. We aimed…
2020 American Transplant Congress
Transplanting Livers from Hepatitis C Virus Positive Donors; Is it Worth the Risk?
J. W. Mensink¹, B. Van Hoek², B. Schaefer³, M. D. Van Rosmalen⁴, I. P. Alwayn⁵, A. E. Braat⁵
¹Leiden University Medical Center, Leiden, Netherlands, ²Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands, ³Dutch Transplant Foundation, Leiden, Netherlands, ⁴Eurotransplant International Foundation, Leiden, Netherlands, ⁵Transplant Surgery, Leiden University Medical Center, Leiden, Netherlands
*Purpose: Before the introduction of Direct-Acting Antivirals (DAAs), only selected organs from Hepatitis C virus (HCV) positive donors were successfully transplanted into HCV positive recipients.…
2020 American Transplant Congress
Survey of Clinician Opinions on Use of Organ Transplants from Hepatitis C Virus Positive Donors: Identifying & Overcoming Barriers
K. Lentine¹, T. Alhamad², D. Peipert³, Y. Caliskan¹, B. Concepcion⁴, R. Forbes⁴, M. Schnitzler¹, Z. Zhang¹, S. Chang², M. Cooper⁵, R. Bloom⁶, R. Mannon⁷, D. Axelrod⁸
¹Saint Louis U, Saint Louis, MO, ²Washington U, Saint Louis, MO, ³Northwestern, Chicago, IL, ⁴Vanderbilt, Nashville, TN, ⁵Georgetown, Washington, DC, ⁶U Penn, Philadelphia, MO, ⁷UAB, Birmingham, AL, ⁸U Iowa, Iowa City, IA
*Purpose: Increasing the use of Hepatitis C Virus (HCV) viremic (Nucleic Acid Testing (NAT)+) donor organs for HCV uninfected (HCV-) patients is a potential approach…